Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Key Points for Treatment of Advanced HNSCC

August 10th 2017

Next Steps in Research for Immunotherapy for HNSCC

August 10th 2017

Immunotherapy in the Peri-Operative Setting of HNSCC

August 10th 2017

Immunotherapy Combinations for HNSCC

August 10th 2017

Emerging Checkpoint Inhibitors for HNSCC

August 10th 2017

Take-Home Messages: Immunotherapy for HNSCC

August 10th 2017

Practical Issues Surrounding Immunotherapy for HNSCC

August 10th 2017

Pseudoprogression on Immunotherapy in HNSCC

August 10th 2017

Immunotherapy for HNSCC

August 10th 2017

New Therapies for HNSCC

August 10th 2017

Refining Chemoradiation for Advanced HNSCC

August 10th 2017

The Role of Induction Chemotherapy in HNSCC

August 10th 2017

Surgery for Locally Advanced HNSCC

August 10th 2017

De-Escalation of Therapy for HPV-Positive HNSCC

August 10th 2017

Personalized Approaches to Head and Neck Cancer Therapy

August 10th 2017

Head and Neck Cancer and the AJCC 8th Edition

August 10th 2017

Genetic Landscape of HNSCC

August 10th 2017

Biology of Head and Neck Cancer

August 10th 2017

Dr. Weiss on Developments in the Treatment of Head and Neck Cancer

August 10th 2017

Jared Weiss, MD, assistant professor, UNC Lineberger Comprehensive Cancer Center, discusses developments of immunotherapy trials for patients with head and neck cancer.

Dr. Cohen on Challenges with Immunotherapy in Head and Neck Cancer

August 9th 2017

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses challenges with immunotherapy in head and neck cancer.